International Journal of Radiation Oncology * Biology * Physics
Volume 73, Issue 4 , Pages 1243-1251 , 15 March 2009

Helical Tomotherapy Planning for Left-Sided Breast Cancer Patients With Positive Lymph Nodes: Comparison to Conventional Multiport Breast Technique

  • S. Murty Goddu, Ph.D.

      Affiliations

    • Washington University School of Medicine, St. Louis, MO
    • Corresponding Author InformationReprint requests to: S. Murty Goddu, Ph.D., Department of Radiation Oncology, Washington University School of Medicine, 4921 Parkview Place, Campus Box 8224, St. Louis, MO 63110. Tel: (314) 362-2635; Fax: (314) 747-9557
    • ,
  • Summer Chaudhari, M.S.

      Affiliations

    • Washington University School of Medicine, St. Louis, MO
    • ,
  • Maria Mamalui-Hunter, Ph.D.

      Affiliations

    • Washington University School of Medicine, St. Louis, MO
    • ,
  • Olga L. Pechenaya, Ph.D.

      Affiliations

    • Washington University School of Medicine, St. Louis, MO
    • ,
  • David Pratt, M.D.

      Affiliations

    • Washington University School of Medicine, St. Louis, MO
    • ,
  • Sasa Mutic, M.S.

      Affiliations

    • Washington University School of Medicine, St. Louis, MO
    • ,
  • Imran Zoberi, M.D.

      Affiliations

    • Washington University School of Medicine, St. Louis, MO
    • ,
  • Sam Jeswani

      Affiliations

    • Tomotherapy Inc., Madison, WI
    • ,
  • Simon N. Powell, M.D., Ph.D.

      Affiliations

    • Washington University School of Medicine, St. Louis, MO
    • Memorial Sloan-Kettering Cancer Center, New York, NY
    • ,
  • Daniel A. Low, Ph.D.

      Affiliations

    • Washington University School of Medicine, St. Louis, MO

Received 29 November 2007 ,Revised 3 November 2008 ,Accepted 4 November 2008.

References 

  1. Ragaz J, Jackson SM, Le N, et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med. 1997;337:956–962
  2. Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy: Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med. 1997;337:949–955
  3. Klein EE, Taylor M, Michaletz-Lorenz M, et al. A mono isocentric technique for breast and regional nodal therapy using dual asymmetric jaws. Int J Radiat Oncol Biol Phys. 1994;28:753–760
  4. Lichter AS, Fraass BA, van de Geijn J, et al. A technique for field matching in primary breast irradiation. Int J Radiat Oncol Biol Phys. 1983;9:263–270
  5. Taylor ME, Perez CA, Halverson KJ, et al. Factors influencing cosmetic results after conservation therapy for breast cancer. Int J Radiat Oncol Biol Phys. 1995;31:753–764
  6. Taghian AG, Assaad SI, Niemierko A, et al. Risk of pneumonitis in breast cancer patients treated with radiation therapy and combination chemotherapy with paclitaxel. J Natl Cancer Inst. 2001;93:1806–1811
  7. Gagliardi G, Bjohle J, Lax I, et al. Radiation pneumonitis after breast cancer irradiation: Analysis of the complication probability using the relative seriality model. Int J Radiat Oncol Biol Phys. 2000;46:373–381
  8. Wennberg B, Gagliardi G, Sundbom L, et al. Early response of lung in breast cancer irradiation: Radiologic density changes measured by CT and symptomatic radiation pneumonitis. Int J Radiat Oncol Biol Phys. 2002;52:1196–1206
  9. Pierce SM, Recht A, Lingos TI, et al. Long-term radiation complications following conservative surgery (CS) and radiation therapy (RT) in patients with early stage breast cancer. Int J Radiat Oncol Biol Phys. 1992;23:915–923
  10. Roychoudhuri R, Robinson D, Putcha V, et al. Increased cardiovascular mortality more than fifteen years after radiotherapy for breast cancer: A population-based study. BMC Cancer. 2007;7:9
  11. Das SK, Baydush AH, Zhou S, et al. Predicting radiotherapy-induced cardiac perfusion defects. Med Phys. 2005;32:19–27
  12. Marks LB, Yu X, Prosnitz RG, et al. The incidence and functional consequences of RT-associated cardiac perfusion defects. Int J Radiat Oncol Biol Phys. 2005;63:214–223
  13. Hurkmans CW, Borger JH, Bos LJ, et al. Cardiac and lung complication probabilities after breast cancer irradiation. Radiother Oncol. 2000;55:145–151
  14. Kestin LL, Sharpe MB, Frazier RC, et al. Intensity modulation to improve dose uniformity with tangential breast radiotherapy: initial clinical experience. Int J Radiat Oncol Biol Phys. 2000;48:1559–1568
  15. Vicini FA, Sharpe M, Kestin L, et al. Optimizing breast cancer treatment efficacy with intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2002;54:1336–1344
  16. Fogliata A, Nicolini G, Alber M, et al. IMRT for breast: A planning study. Radiother Oncol. 2005;76:300–310
  17. Popescu CC, Olivotto I, Patenaude V, et al. Inverse-planned, dynamic, multi-beam, intensity-modulated radiation therapy (IMRT): A promising technique when target volume is the left breast and internal mammary lymph nodes. Med Dosim. 2006;31:283–291
  18. Gonzalez VJ, Buchholz DJ, Langen KM, et al. Evaluation of two tomotherapy-based techniques for the delivery of whole-breast intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2006;65:284–290
  19. Bentel GC. First place 1989 Alpha Cradle Award winner: Positioning and immobilization device for patients receiving radiation therapy for carcinoma of the breast. Med Dosim. 1990;15:3–6
  20. van Asselen B, Raaijmakers CP, Hofman P, et al. An improved breast irradiation technique using three-dimensional geometrical information and intensity modulation. Radiother Oncol. 2001;58:341–347
  21. Kissick MW, Fenwick J, James JA, et al. The helical tomotherapy thread effect. Med Phys. 2005;32:1414–1423
  22. Seppenwoolde Y, Lebesque JV, de Jaeger K, et al. Comparing different NTCP models that predict the incidence of radiation pneumonitis: Normal tissue complication probability. Int J Radiat Oncol Biol Phys. 2003;55:724–735
  23. Graham MV, Purdy JA, Emami B, et al. Clinical dose–volume histogram analysis for pneumonitis after 3D treatment for non–small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys. 1999;45:323–329
  24. Hernando ML, Marks LB, Bentel GC, et al. Radiation-induced pulmonary toxicity: A dose–volume histogram analysis in 201 patients with lung cancer. Int J Radiat Oncol Biol Phys. 2001;51:650–659
  25. Wang S, Liao Z, Wei X, et al. Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non–small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT). Int J Radiat Oncol Biol Phys. 2006;66:1399–1407
  26. Krueger EA, Fraass BA, McShan DL, et al. Potential gains for irradiation of chest wall and regional nodes with intensity modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2003;56:1023–1037
  27. Ramsey CR, Seibert RM, Robison B, et al. Helical tomotherapy superficial dose measurements. Med Phys. 2007;34:3286–3293
  28. Higgins PD, Han EY, Yuan JL, et al. Evaluation of surface and superficial dose for head and neck treatments using conventional or intensity-modulated techniques. Phys Med Biol. 2007;52:1135–1146
  29. Minor GI, Yashar CM, Spanos WJ, et al. The relationship of radiation pneumonitis to treated lung volume in breast conservation therapy. Breast J. 2006;12:48–52
  30. Lingos TI, Recht A, Vicini F, et al. Radiation pneumonitis in breast cancer patients treated with conservative surgery and radiation therapy. Int J Radiat Oncol Biol Phys. 1991;21:355–360
  31. Campone M, Fumoleau P, Bourbouloux E, et al. Taxanes in adjuvant breast cancer setting: which standard in Europe?. Crit Rev Oncol Hematol. 2005;55:167–175
  32. Giordano SH, Duan Z, Kuo YF, et al. Impact of a scientific presentation on community treatment patterns for primary breast cancer. J Natl Cancer Inst. 2006;98:382–388
  33. Taghian AG, Assaad SI, Niemierko A, et al. Is a reduction in radiation lung volume and dose necessary with paclitaxel chemotherapy for node-positive breast cancer?. Int J Radiat Oncol Biol Phys. 2005;62:386–391
  34. Hojris I, Overgaard M, Christensen JJ, et al. Radiotherapy Committee of the Danish Breast Cancer Cooperative Group Morbidity and mortality of ischaemic heart disease in high-risk breast-cancer patients after adjuvant postmastectomy systemic treatment with or without radiotherapy: Analysis of DBCG 82b and 82c randomised trials. Lancet. 1999;354:1425–1430
  35. Boice JD, Harvey EB, Blettner M, et al. Cancer in the contralateral breast after radiotherapy for breast cancer. N Engl J Med. 1992;326:1243–1251

 Conflict of interest: Supported in part by a grant from Tomotherapy Inc., Madison, WI.

PII: S0360-3016(08)03735-8

doi: 10.1016/j.ijrobp.2008.11.004

International Journal of Radiation Oncology * Biology * Physics
Volume 73, Issue 4 , Pages 1243-1251 , 15 March 2009

Article Tools

* Image Usage & Resolution